Genomics and epigenetics are increasingly recognized as critical factors influencing individual responses to toxicants and drugs. These fields explore how genetic variations and heritable changes in gene expression without DNA sequence alteration impact susceptibility to adverse effects and toxicological mechanisms. Genomic studies involve analyzing single nucleotide polymorphisms (SNPs), copy number variations, and gene expression profiles…
Pharmacokinetics (PK) and toxicokinetics (TK) are critical components of drug development, focusing on the absorption, distribution, metabolism, and excretion (ADME) of compounds and their toxicological profiles. PK characterizes how a drug moves through the body, while TK evaluates the relationship between exposure and toxic effects. In preclinical studies, PK/TK analyses help determine dosing regimens, bioavailability,…
Preclinical toxicology is undergoing a transformation driven by innovative technologies that enhance data quality, reduce animal usage, and improve predictive accuracy for human safety. These emerging tools include advanced in vitro models, high-content imaging, omics platforms, computational toxicology, and digital pathology. Three-dimensional (3D) cell cultures, organoids, and microphysiological systems replicate tissue architecture and function more…
Biomarkers have become indispensable tools in toxicology and drug safety assessment, providing measurable indicators of biological processes, pathogenic responses, or pharmacologic effects. Their use enhances the sensitivity and specificity of toxicity detection, facilitates early identification of adverse effects, and supports mechanistic understanding of drug action. Biomarkers can be classified into several types: diagnostic, prognostic, predictive,…
Regulatory guidelines for preclinical toxicology establish the framework and standards to ensure that nonclinical safety studies are scientifically valid, reliable, and acceptable to regulatory authorities worldwide. These guidelines provide critical directions for the design, conduct, and reporting of toxicology studies supporting Investigational New Drug (IND) applications and New Drug Applications (NDA). International bodies such as…
Pharmacodynamics (PD) is a fundamental aspect of preclinical research that focuses on understanding the biochemical, molecular, and physiological effects of drugs on living organisms. It addresses how a drug interacts with its biological target and the subsequent cellular and systemic responses. These studies provide critical insight into a drug’s mechanism of action, efficacy, and safety,…
Good Laboratory Practice (GLP) compliance is essential for preclinical toxicology studies to ensure data integrity, reproducibility, and regulatory acceptance. GLP standards provide a structured framework covering study planning, conduct, data collection, reporting, and quality assurance. Designing a GLP-compliant study begins with a clear statement of objectives, including selection of relevant animal species, dose levels, and…
Histopathology is a cornerstone of preclinical toxicology studies, providing detailed microscopic analysis of tissue architecture and cellular morphology to detect and characterize adverse effects caused by investigational compounds. Unlike biochemical assays or molecular biomarkers that offer indirect evidence of toxicity, histopathology delivers direct visualization of tissue damage, inflammation, degeneration, and repair processes, making it indispensable…
Pharmacokinetics (PK) and toxicokinetics (TK) are critical components of drug development, providing quantitative data on the absorption, distribution, metabolism, and excretion (ADME) of compounds, as well as their concentration–time profiles related to toxic effects. Understanding PK and TK helps optimize dosing regimens, predict human responses, and assess safety margins. Pharmacokinetic studies focus on characterizing drug…
The pursuit of alternatives to animal testing in toxicology has gained significant momentum, driven by ethical considerations, regulatory encouragement, and technological advancements. In vitro methods provide controlled, reproducible platforms to evaluate toxicity while reducing animal use, costs, and study durations. Cell-based assays using primary cells, immortalized cell lines, or stem cell–derived differentiated cells allow assessment…